Literature DB >> 12370443

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase.

James Leiper1, Judith Murray-Rust, Neil McDonald, Patrick Vallance.   

Abstract

The enzyme dimethylarginine dimethylaminohydrolase (DDAH) hydrolyses asymmetrically methylated arginine residues that are endogenously produced inhibitors of nitric oxide synthases (NOS). We and others have proposed that DDAH activity is a key determinant of intracellular methylarginine concentrations and that factors that regulate the activity of DDAH may modulate nitric oxide (NO) production in vivo. We recently solved the crystal structure of a bacterial DDAH and identified a Cys-His-Glu catalytic triad [Murray-Rust, J., Leiper, J. M., McAlister, M., Phelan, J., Tilley, S., Santa Maria, J., Vallance, P. & McDonald, N. (2001) Nat. Struct. Biol. 8, 679-683]. The presence of a reactive cysteine residue (Cys-249) in the active site of DDAH raised the possibility that DDAH activity might be directly regulated by S-nitrosylation of this residue by NO. In the present study, we demonstrate that recombinant DDAH is reversibly inhibited after incubation with NO donors in vitro. Similarly mammalian DDAH in cytosolic extracts is also reversibly inhibited by NO donors. In cultured endothelial cells, heterologously expressed human DDAH II was S-nitrosylated after cytokine induced expression of the inducible NOS isoforms. The implication of these findings is that under certain conditions when NO generation increases, S-nitrosylation diminishes DDAH activity and this would be expected to lead to accumulation of asymmetric dimethylarginine and inhibition of NOS. This observation may help explain why expression of iNOS often leads to inhibition of activity of constitutively expressed NOS isozymes. We also identify Cys-His-Glu as a nitrosylation motif that is conserved in a family of arginine handling enzymes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370443      PMCID: PMC129707          DOI: 10.1073/pnas.212269799

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  S-nitrosylation: spectrum and specificity.

Authors:  D T Hess; A Matsumoto; R Nudelman; J S Stamler
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

Review 2.  Nitrosylation. the prototypic redox-based signaling mechanism.

Authors:  J S Stamler; S Lamas; F C Fang
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

3.  Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase.

Authors:  J Murray-Rust; J Leiper; M McAlister; J Phelan; S Tilley; J Santa Maria; P Vallance; N McDonald
Journal:  Nat Struct Biol       Date:  2001-08

4.  Basal and stimulated protein S-nitrosylation in multiple cell types and tissues.

Authors:  Andrew J Gow; Qiping Chen; Douglas T Hess; Brian J Day; Harry Ischiropoulos; Jonathan S Stamler
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

5.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

Authors:  C Zoccali; S Bode-Böger; F Mallamaci; F Benedetto; G Tripepi; L Malatino; A Cataliotti; I Bellanuova; I Fermo; J Frölich; R Böger
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

6.  Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins.

Authors:  C T Tran; M F Fox; P Vallance; J M Leiper
Journal:  Genomics       Date:  2000-08-15       Impact factor: 5.736

7.  Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms.

Authors:  Y M Kim; R V Talanian; T R Billiar
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

Review 8.  Biological significance of endogenous methylarginines that inhibit nitric oxide synthases.

Authors:  J Leiper; P Vallance
Journal:  Cardiovasc Res       Date:  1999-08-15       Impact factor: 10.787

9.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide.

Authors:  S R Jaffrey; H Erdjument-Bromage; C D Ferris; P Tempst; S H Snyder
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

10.  Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney.

Authors:  T Ogawa; M Kimoto; K Sasaoka
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

View more
  69 in total

Review 1.  Clinical Relevance of Biomarkers of Oxidative Stress.

Authors:  Jeroen Frijhoff; Paul G Winyard; Neven Zarkovic; Sean S Davies; Roland Stocker; David Cheng; Annie R Knight; Emma Louise Taylor; Jeannette Oettrich; Tatjana Ruskovska; Ana Cipak Gasparovic; Antonio Cuadrado; Daniela Weber; Henrik Enghusen Poulsen; Tilman Grune; Harald H H W Schmidt; Pietro Ghezzi
Journal:  Antioxid Redox Signal       Date:  2015-10-26       Impact factor: 8.401

2.  Determination of dimethylarginine dimethylaminohydrolase activity in the kidney.

Authors:  Y-L Tain; C Baylis
Journal:  Kidney Int       Date:  2007-07-25       Impact factor: 10.612

3.  Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease.

Authors:  Jennifer J Dupont; William B Farquhar; Raymond R Townsend; David G Edwards
Journal:  J Appl Physiol (1985)       Date:  2011-09-01

4.  Nitrogen balance in the ecosystem of the cystic fibrosis lung.

Authors:  Nadzeya V Marozkina; Benjamin Gaston
Journal:  Am J Respir Crit Care Med       Date:  2011-05-15       Impact factor: 21.405

5.  Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.

Authors:  Johannes Jacobi; Renke Maas; Arturo J Cardounel; Michaela Arend; Arthur J Pope; Nada Cordasic; Juliane Heusinger-Ribeiro; Dorothee Atzler; Joachim Strobel; Edzard Schwedhelm; Rainer H Böger; Karl F Hilgers
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

6.  The antihypertensive effect of arginine.

Authors:  Sudesh Vasdev; Vicki Gill
Journal:  Int J Angiol       Date:  2008

Review 7.  The association between systemic sclerosis, arginine and asymmetric dimethylarginine.

Authors:  Li Zhang; Ya-Nan Wan; Jiu-Hua Zhao; Yu-Jie Wang; Ying-Xin Wang; Jun-Wei Yan; Xiao-Lei Huang; Jing Wang
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

8.  Identification of small-molecule enhancers of arginine methylation catalyzed by coactivator-associated arginine methyltransferase 1.

Authors:  Sabrina Castellano; Astrid Spannhoff; Ciro Milite; Fabrizio Dal Piaz; Donghang Cheng; Alessandra Tosco; Monica Viviano; Abdellah Yamani; Agostino Cianciulli; Marina Sala; Vincent Cura; Jean Cavarelli; Ettore Novellino; Antonello Mai; Mark T Bedford; Gianluca Sbardella
Journal:  J Med Chem       Date:  2012-11-02       Impact factor: 7.446

Review 9.  Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.

Authors:  R M Pluta
Journal:  Acta Neurochir Suppl       Date:  2008

10.  Dimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis.

Authors:  K Park; D G Lee; S W Kim; J-S Paick
Journal:  Int J Impot Res       Date:  2009-06-18       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.